Dan Bushell is a strategic executive who has led complex partnerships across discovery, development, and commercialization stages at leading biopharmaceutical companies. Expertise includes managing multi-party alliances with major pharmaceutical companies coordinating cross-functional teams, negotiating contract amendments, and ensuring contractual compliance while advancing therapeutic programs.

Notable achievements include establishing an AI partnership assessment framework by benchmarking 50+ industry deals, structuring an authorized generic licensing strategy that enabled ~$100M in revenue, crafting a comprehensive Latin American market expansion plan, and building IT infrastructure at Gilead to support nine product launches while optimizing tactical expenditures. Demonstrated success in financial modeling, governance framework development, conflict resolution, and driving operational efficiency across scientific, commercial, and regulatory functions in both large global pharmaceutical companies and mid-sized biotech organizations.